allogeneic stem cell transplantation
Caspofungin as secondary prophylaxis or therapy in patients undergoing allogeneic stem cell transplantation with a prior or ongoing history of systemic or invasive fungal infections -- N. Stute, T. Zabelina, N. Fehse, W. Hassenpflug, J. Panse, C. Wolschke, F. Ayuk, H. Schieder, H. Renges, A. Kratochwille, R. von Hinüber, R. Erttmann, A.R. Zander, N. Kröger -- CTT December 2008;1(2)
Invasive fungal diseases in patients after allogeneic hematopoietic stem cell transplantation -- N.I. Zubarovskaya, E.V. Semenova, N.V. Stancheva, V.N. Vavilov, I.V. Kazantsev, Yu.G. Vasilieva, N.N. Klimko, B.V. Afanasyev -- CTT December 2009;1(3)
funded by:
